Search Results - "Rilling WS"

ASO Author Reflections: Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.

Authors: Sugumar K Ocuin LM

Source: Annals of surgical oncology [Ann Surg Oncol] 2024 Jul; Vol. 31 (7), pp. 4460-4461. Date of Electronic Publication: 2024 Apr 28.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; PubMed not MEDLINE

International multisociety Delphi consensus for liver tumour thermal ablation: margin assessment.

Authors: Paolucci I Overduin CG Johnston EW et al.

Source: The Lancet. Oncology [Lancet Oncol] 2026 May; Vol. 27 (5), pp. e248-e258.

Publication Type: Consensus Statement; Journal Article

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

International multisociety Delphi consensus for liver tumour thermal ablation: procedural and practice standards.

Authors: Laimer G Johnston EW Overduin CG et al.

Source: The Lancet. Oncology [Lancet Oncol] 2026 May; Vol. 27 (5), pp. e259-e270.

Publication Type: Journal Article; Consensus Statement; Review

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Real-time 3D confirmation of complete ablation with margins as a local cure for colorectal liver metastases: the ACCLAIM trial.

Authors: Sofocleous CT Callstrom MR Petre EN et al.

Source: Trials [Trials] 2025 Sep 26; Vol. 26 (1), pp. 360. Date of Electronic Publication: 2025 Sep 26.

Publication Type: Journal Article; Clinical Trial Protocol

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

Prognostic value of alpha-fetoprotein and des-gamma-carboxyprothrombin in hepatocellular carcinoma treated with transarterial chemoembolization.

Authors: Liu, Zhao Guo, Yapan Wang, Peng et al.

Source: Journal of Cancer Research & Therapeutics. Nov2025, Vol. 21 Issue 6, p1121-1130. 10p.

Multicenter, prospective clinical trial for balloon-occluded alternative infusion of cisplatin solution and fragmented gelatin particles of transarterial chemoembolization for hepatocellular carcinoma beyond up-to-seven criteria.

Authors: Hoshiai, Sodai Hasegawa, Naoyuki Yamada, Takeshi et al.

Source: Scientific Reports. 5/13/2025, Vol. 15 Issue 1, p1-10. 10p.

Comparative efficacy and safety of immune checkpoint inhibitors combined with antiangiogenic agents for unresectable hepatocellular carcinoma in patients with Child-Pugh A versus B cirrhosis: a single-center, retrospective study.

Authors: Liu, Dan Yang, Zirong Wang, Lilin et al.

Source: BMC Cancer. 10/27/2025, Vol. 25 Issue 1, p1-9. 9p.

Investigation of the Partial Volume Effect in Pre-Dosimetry of Liver Tumors for ⁹⁰Y Radioembolization: A Phantom Study.

Alternate Title: 90Y Radyoembolizasyon Tedavisinde Karaciğer Tümörleri Pre-Dozimetri'de Kısmi Hacim Etkisinin İncelenmesi: Bir Fantom Çalışması.

Authors: Akar, Ayşe Dilaver Yeyin, Nami Akyol, Sinem et al.

Source: Molecular Imaging & Radionuclide Therapy. 2025, Vol. 34 Issue 3, p180-187. 8p.

2024 multidisciplinary consensus on image‐guided lung tumor ablation from the Taiwan Academy of Tumor Ablation.

Authors: Chang, Ling Kai Yang, Shun Mao Chien, Ning et al.

Source: Thoracic Cancer. Jul2024, Vol. 15 Issue 20, p1607-1613. 7p.

First rib resection and corrective clavicle osteotomy using the infraclavicular approach for thoracic outlet syndrome due to clavicle malunion: A case report.

Authors: Furuhata, Ryogo Tanji, Atsushi Suzuki, Taku et al.

Source: BMC Musculoskeletal Disorders. 7/4/2025, Vol. 26 Issue 1, p1-7. 7p.

Identification of transarterial chemoembolization candidates in advanced hepatocellular carcinoma patients classified solely by performance status 1: a multicenter retrospective study.

Authors: Li, Jing Wang, Zhexuan Ma, Litian et al.

Source: Scientific Reports. 5/29/2025, Vol. 15 Issue 1, p1-10. 10p.

Evaluation of long axial field-of-view (LAFOV) PET/CT for post-treatment dosimetry in Yttrium-90 radioembolization of liver tumors: a comparative study with conventional SPECT imaging.

Authors: Zeimpekis, Konstantinos G. Sari, Hasan Gözlügöl, Nasir et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Mar2025, Vol. 52 Issue 4, p1460-1471. 12p.

A positive feedback loop between TKT and c-Myc drives TACE resistance in hepatocellular carcinoma.

Authors: Xiao Y Liu M Zhou Y et al.

Source: Cell death discovery [Cell Death Discov] 2026 Apr 21; Vol. 12 (1). Date of Electronic Publication: 2026 Apr 21.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE

Conversion therapy using transarterial chemoembolization plus tislelizumab for unresectable hepatocellular carcinoma: effects on tumor necrosis and anti-tumor immune response.

Authors: Yao Q Chen G Yu Y et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Jun; Vol. 28 (6), pp. 2208-2218. Date of Electronic Publication: 2026 Jan 06.

Publication Type: Journal Article

Journal Info: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Degradable starch microspheres transarterial chemoembolization (DSM-TACE) in patients with unresectable hepatocellular carcinoma: results from the Prospective Multicenter Observational HepaStar Trial.

Authors: Collettini, Federico Andrašina, Tomáš Reimer, Peter et al.

Source: European Radiology. Jul2025, Vol. 35 Issue 7, p4132-4140. 9p.

Subjects: Hepatocellular carcinoma, Chemoembolization, Safety, Adverse health care events, Biomaterials, Clinical trials, Overall survival, Cancer prognosis

Geographic Terms: Europe

Construction of a prognostic model based on disulfidptosis-related genes and identification of CCNA2 as a novel biomarker for hepatocellular carcinoma.

Authors: Wang, Tao Li, Wenxuan Wu, Yuelan et al.

Source: Biology Direct. 12/19/2024, Vol. 19 Issue 1, p1-18. 18p.

Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study.

Authors: Zhang, Ying Numata, Kazushi Imajo, Kento et al.

Source: Hepatology Research. Dec2024, Vol. 54 Issue 12, p1174-1192. 19p.

Comprehensive treatment for two patients with small cell neuroendocrine carcinoma of the liver: A case report and literature review.

Authors: Feng, Ruizeng Wang, Hao Zhao, Yang et al.

Source: Oncology Letters. May2026, Vol. 31 Issue 5, pN.PAG-N.PAG. 1p.

Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis.

Authors: Fan, Wenzhe Zhu, Bowen Yue, Shufan et al.

Source: Cancer Medicine. Jan2023, Vol. 12 Issue 1, p61-72. 12p.

Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma.

Authors: Hou, Changlong Xiong, Baizhu Zhou, Lei et al.

Source: BMC Cancer. 3/27/2024, Vol. 24 Issue 1, p1-12. 12p.